These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9353024)

  • 1. Detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins confers protection against otitis media in chinchillas.
    Gu XX; Sun J; Jin S; Barenkamp SJ; Lim DJ; Robbins JB; Battey J
    Infect Immun; 1997 Nov; 65(11):4488-93. PubMed ID: 9353024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection against nontypeable Haemophilus influenzae challenges by mucosal vaccination with a detoxified lipooligosaccharide conjugate in two chinchilla models.
    Hong W; Peng D; Rivera M; Gu XX
    Microbes Infect; 2010 Jan; 12(1):11-8. PubMed ID: 19782149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological activities of antibodies elicited by lipooligosaccharide based-conjugate vaccines of nontypeable Haemophilus influenzae in an otitis media model.
    Sun J; Chen J; Cheng Z; Robbins JB; Battey JF; Gu XX
    Vaccine; 2000 Jan; 18(13):1264-72. PubMed ID: 10649628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization with high-molecular-weight adhesion proteins of nontypeable Haemophilus influenzae modifies experimental otitis media in chinchillas.
    Barenkamp SJ
    Infect Immun; 1996 Apr; 64(4):1246-51. PubMed ID: 8606086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, characterization, and immunologic properties of detoxified lipooligosaccharide from nontypeable Haemophilus influenzae conjugated to proteins.
    Gu XX; Tsai CM; Ueyama T; Barenkamp SJ; Robbins JB; Lim DJ
    Infect Immun; 1996 Oct; 64(10):4047-53. PubMed ID: 8926067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with outer membrane protein P6 from nontypeable Haemophilus influenzae induces bactericidal antibody and affords protection in the chinchilla model of otitis media.
    DeMaria TF; Murwin DM; Leake ER
    Infect Immun; 1996 Dec; 64(12):5187-92. PubMed ID: 8945564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal immunization with a lipooligosaccharide-based conjugate vaccine from nontypeable Haemophilus influenzae enhances bacterial clearance in mouse nasopharynx.
    Hirano T; Hou Y; Jiao X; Gu XX
    FEMS Immunol Med Microbiol; 2003 Jan; 35(1):1-10. PubMed ID: 12589951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outer membrane proteins as a carrier for detoxified lipooligosaccharide conjugate vaccines for nontypeable Haemophilus influenzae.
    Wu TH; Gu XX
    Infect Immun; 1999 Oct; 67(10):5508-13. PubMed ID: 10496940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity of Nontypeable Haemophilus influenzae Outer Membrane Vesicles and Protective Ability in the Chinchilla Model of Otitis Media.
    Winter LE; Barenkamp SJ
    Clin Vaccine Immunol; 2017 Oct; 24(10):. PubMed ID: 28768669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of mixtures of purified Haemophilus influenzae outer membrane proteins in protection against challenge with nontypeable H. influenzae in the chinchilla otitis media model.
    Green BA; Vazquez ME; Zlotnick GW; Quigley-Reape G; Swarts JD; Green I; Cowell JL; Bluestone CD; Doyle WJ
    Infect Immun; 1993 May; 61(5):1950-7. PubMed ID: 8478084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of clearance of bacteria from murine lungs by immunization with detoxified lipooligosaccharide from Moraxella catarrhalis conjugated to proteins.
    Hu WG; Chen J; Battey JF; Gu XX
    Infect Immun; 2000 Sep; 68(9):4980-5. PubMed ID: 10948114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Passive transfer of antiserum specific for immunogens derived from a nontypeable Haemophilus influenzae adhesin and lipoprotein D prevents otitis media after heterologous challenge.
    Kennedy BJ; Novotny LA; Jurcisek JA; Lobet Y; Bakaletz LO
    Infect Immun; 2000 May; 68(5):2756-65. PubMed ID: 10768970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bacterial vaccine polypeptide protective against nontypable Haemophilus influenzae.
    Whitby PW; Morton DJ; Mussa HJ; Mirea L; Stull TL
    Vaccine; 2020 Mar; 38(14):2960-2970. PubMed ID: 32111525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological characterisation of truncated lipooligosaccharide-outer membrane protein based conjugate vaccine against Moraxella catarrhalis and nontypeable Haemophilus influenzae.
    Singh S; Wilson JC; Cripps AW; Massa H; Ozberk V; Grice ID; Peak IR
    Vaccine; 2020 Jan; 38(2):309-317. PubMed ID: 31668366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and characterization of lipooligosaccharide-based conjugates as vaccine candidates for Moraxella (Branhamella) catarrhalis.
    Gu XX; Chen J; Barenkamp SJ; Robbins JB; Tsai CM; Lim DJ; Battey J
    Infect Immun; 1998 May; 66(5):1891-7. PubMed ID: 9573066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylcholine decreases early inflammation and promotes the establishment of stable biofilm communities of nontypeable Haemophilus influenzae strain 86-028NP in a chinchilla model of otitis media.
    Hong W; Mason K; Jurcisek J; Novotny L; Bakaletz LO; Swords WE
    Infect Immun; 2007 Feb; 75(2):958-65. PubMed ID: 17130253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of peptide mimotopes of lipooligosaccharide from nontypeable Haemophilus influenzae as vaccine candidates.
    Hou Y; Gu XX
    J Immunol; 2003 Apr; 170(8):4373-9. PubMed ID: 12682274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and characterization of lipooligosaccharide-based conjugate vaccines for serotype B Moraxella catarrhalis.
    Yu S; Gu XX
    Infect Immun; 2005 May; 73(5):2790-6. PubMed ID: 15845482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of common lipooligosaccharide types in isolates from patients with otitis media by monoclonal antibodies against nontypeable Haemophilus influenzae 9274.
    Ueyama T; Gu XX; Tsai CM; Karpas AB; Lim DJ
    Clin Diagn Lab Immunol; 1999 Jan; 6(1):96-100. PubMed ID: 9874671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal immunization enhances clearance of nontypeable Haemophilus influenzae and reduces stimulation of tumor necrosis factor alpha production in the murine model of otitis media.
    Sabirov A; Kodama S; Hirano T; Suzuki M; Mogi G
    Infect Immun; 2001 May; 69(5):2964-71. PubMed ID: 11292713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.